Study Finds that CE Increases Provider Competence
A study recently published in the Journal of the American Society of Nephrology found that healthcare providers who manage…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Yearly Archives
2019
Senate Finance Committee Releases Updated Drug Pricing Bill and Extender…
Recently, Senator Chuck Grassley and Senator Ron Wyden released an updated version of their drug pricing legislation, including…
Deval Patrick: Will Healthcare Ties Help His Campaign?
In the current race for 2020 Democratic presidential candidate, there are a slew of viable candidates. Despite largely agreeing on…
Analysis of Accountable Care Organizations Shows Significant Savings
A recent analysis found that accountable care organizations (ACOs) reduced Medicare spending by $755 million from 2013 to 2017.…
CMS Survey of 340B Drug Prices Garners Hospital Pushback
As reported initially by FierceHealthcare, hospitals are blasting the Trump administration’s move to survey them about drugs…
HHS and FDA Unveil Proposed Rules on Drug Importations
On December 18, 2019, the United States Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA)…
FDA Guidance on Adaptive Clinical Trials Design
The US Food and Drug Administration (FDA) last week finalized guidance on adaptive clinical trial designs for drugs and biologics.…
Biologic Exclusivity Provision Removed from USCMA Agreement
5Recently, officials from the United States, Mexico, and Canada signed a new United States-Mexico-Canada trade agreement (USMCA).…
FDA Releases Report on Drug Shortages and Encourages Manufacturer Quality…
The Food and Drug Administration (“FDA”) Drug Shortages Task Force recently released a report, entitled Drug Shortages: Root…
Insys Executives’ Convictions Partially Overturned
The story of Insys Therapeutics continues to get more interesting. In the first criminal trial of pharmaceutical executives…